Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications

N Mahmood, C Mihalcioiu, SA Rabbani - Frontiers in oncology, 2018 - frontiersin.org
The plasminogen activator (PA) system is an extracellular proteolytic enzyme system
associated with various physiological and pathophysiological processes. A large body of …

The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies

SC Su, CW Lin, WE Yang, WL Fan… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: The urokinase plasminogen activator (uPA) system, comprising the serine
protease uPA, its cognate receptor, uPAR, and two endogenous inhibitors, plasminogen …

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival …

SMK Pulukuri, CS Gondi, SS Lakka, A Jutla… - Journal of biological …, 2005 - ASBMB
The invasive ability of tumor cells plays a key role in prostate cancer metastasis and is a
major cause of treatment failure. Urokinase plasminogen activator-(uPA) and its receptor …

Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells

AK Nalla, B Gorantla, CS Gondi, SS Lakka… - Cancer gene therapy, 2010 - nature.com
Prostate cancer is one of the most commonly diagnosed cancers and the second leading
cause of cancer deaths in Americans. The high mortality rate is mainly attributed to the …

Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy

AP Mazar - Clinical cancer research, 2008 - AACR
The urokinase plasminogen activator receptor (uPAR) has been implicated in the growth,
metastasis, and angiogenesis of several solid and hemotologic malignancies. uPAR is part …

Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?

N Montuori, V Visconte, G Rossi… - Thrombosis and …, 2005 - thieme-connect.com
The urokinase-mediated plasminogen activation (PA) system is involved in many
physiological and pathological events that include cell migration and tissue remodelling …

Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study

P Matarrese, B Ascione, L Ciarlo, R Vona, C Leonetti… - Molecular cancer, 2010 - Springer
Background Cathepsins represent a group of proteases involved in determining the
metastatic potential of cancer cells. Among these are cysteinyl-(eg cathepsin B and …

[PDF][PDF] The urokinase receptor as an entertainer of signal transduction

S D'Alessio, F Blasi - Front Biosci, 2009 - article.imrpress.com
[Frontiers in Bioscience 14, 4575-4587, January 1, 2009] 4575 The urokinase receptor as an
entertainer of signal transduction Si Page 1 [Frontiers in Bioscience 14, 4575-4587, January 1 …

The urokinase plasminogen activator receptor as a gene therapy target for cancer

V Pillay, CR Dass, PFM Choong - Trends in biotechnology, 2007 - cell.com
Urokinase plasminogen activator (uPA) and/or its receptor (uPAR) are essential for
metastasis, and overexpression of these molecules is strongly correlated with poor …

Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic

AP Mazar, RW Ahn… - Current pharmaceutical …, 2011 - ingentaconnect.com
The urokinase plasminogen activator receptor (uPAR) mediates cell motility and tissue
remodeling. Although uPAR may be expressed transiently in many tissues during …